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INTRODUCTION

V

itamin D is a fat-soluble steroid hormone that is
produced when the skin is exposed to sunlight
(1). It is involved in the reduction of inflammation,
modulation of cell growth, normal functioning
of the nervous and immune systems, and bone
metabolism (2). The human body obtains >80%
of vitamin D when ultraviolet-B radiation (UV-B)
converts 7-dehydrocholesterol in epidermal and
dermal cells to 25-hydroxyvitamin D; 25OHD (3,4).
This metabolite is subsequently hydroxylated in the
liver and kidney to form 1,25-dihydroxyvitamin D;
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1,25(OH)2D (3,4). Vitamin D (~20%) may also be
supplied via the diet (3,4).
25OHD has a long half-life in the circulation
and its concentration is not under tight homeostatic
regulation (5,6). It is therefore useful for measuring
the levels of vitamin D in the human body (5,6). It
may be assayed by chromatographic, spectroscopic, or
immunosorbent techniques including high-pressure
liquid chromatography, liquid chromatographytandem mass spectroscopy, radioimmunoassays, and
competitive protein binding assays (7). The analysis and
interpretation of 25OHD is made by using thresholds
1
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Objective: To determine the prevalence of vitamin D deficiency (VDD) in exclusively breastfed
infants at the Aga Khan University Hospital Nairobi, Kenya (AKUHN). The relationships between
25-hydroxyvitamin D; 25OHD, parathyroid hormone (PTH), maternal vitamin D supplementation, and
sunlight exposure were also determined. Subjects and methods: Blood from 98 infants was assayed
for 25OHD, calcium, phosphate, and PTH. Socio-demographic and clinical characteristics were
analyzed using descriptive statistics and inferential analysis (p < 0.05). Results: The prevalence of
VDD (25OHD <12 ng/mL), vitamin D insufficiency (VDI, 25OHD 12-20 ng/mL) and vitamin D sufficiency
(VDS, 25OHD >20 ng/mL) was 11.2% (95% CI 8.0%-14.4%), 12.2% (95% CI 8.9%-15.5%), and 76.5%
(95% CI 72.3%-80.8%) respectively. There was no difference in the mean age, head circumference,
length, or weight of infants in VDD, VDI, and VDS groups. PTH was elevated when 25OHD was
<12 ng/mL and normal when 25OHD was between 12-20 ng/mL. 25OHD and PTH were normal in
infants whose mothers received vitamin D supplements. Infants who received <30 minutes/day of
exposure to sunlight were 5 times more likely to have VDI than infants who received ≥30 minutes/day
(p = 0.042). Conclusions: The prevalence of VDD in exclusively breastfed infants at AKUHN is low.
The current national policy that recommends exclusive breastfeeding of infants in the first 6 months
of life appears to be effective in staving off vitamin D deficiency but those infants with < 30 minutes
sunlight exposure may benefit from low dose supplemental vitamin D during times of low sunlight
exposure.

VDD in exclusively breastfed infants

of <12 ng/mL, 12-20 ng/mL, and >20 ng/mL to
denote vitamin D deficiency, vitamin D insufficiency and
vitamin D sufficiency respectively in keeping with the
recommendations of several global health authorities
including the American Institute Of Medicine (IOM),
the UK Scientific Advisory Committee on Nutrition
(SACN), the Nordic Nutritional Recommendations
(NNR), and the European Food Safety Authority
(EFSA) (8-11).
Severe VDD causes osteomalacia in adults and rickets
in children (12-14). However, because vitamin D is
physiologically involved in other body systems, health
impacts such as osteoporosis, breast cancer, and preeclampsia may also be realized (12-14). Estimates
suggest that up to a billion people are affected by VDD
and VDI worldwide (15). Exclusively breastfed infants
are particularly vulnerable to VDD and maternal VDD
during pregnancy has been identified as one of the major
contributors of VDD in infants (16). For example, at
AKUHN, eight out of every ten-term newborn infants
are born to vitamin-D-deficient mothers (16).
The National Nutrition Action Plan is a policy in
Kenya that recommends the exclusive breastfeeding
of infants until they are six months of age (17).
While breastfeeding is the recommended method of
infant feeding and provides infants with the necessary
nutrients and immune factors, breast milk provides only
about 10-80 IU/L of vitamin D which is short of the
recommended 400 IU and is likely to result in VDD
(18). By evaluating the prevalence of VDD among
exclusively breastfed infants in the region, the scope
of VDD as a public health problem can be realized.
Presently, this data is not available. This study, therefore,
aims to fill this gap by determining the prevalence of
VDD among exclusively breastfed infants at AKUHN,
a private referral hospital in Nairobi, Kenya. The
relationship between 25OHD, PTH, maternal vitamin
D supplementation, and sunlight exposure was also
determined.
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SUBJECTS AND METHODS
Study setting
The Aga Khan University Hospital (AKUHN) is a
private referral hospital that serves residents of Nairobi
and the wider East African region (19). This institution
offers both outpatient and inpatient pediatric services
2

(19). A well-baby clinic is also available which provides
immunization services and growth monitoring for
infants and children under the age of five years (19).
On average, 30 infants aged three to six months are
seen at the hospital per week (19).

Ethical considerations
Ethical approval was sought from the ethics committee
at the Aga Khan University Hospital; AKUHN (REF:
2014/REC-23 (v2); Supplementary data; Appendix I).
The purpose of the study was carefully explained to all
the mothers of participating infants and an opportunity
was provided to them to seek clarifications regarding
the study. Mothers were requested to sign an informed
consent form detailing the terms of participation
(Supplementary data; Appendix II). Mothers were free
to withdraw their child from the study at any time.
In keeping with the guidelines of the Department of
Pediatrics at AKUHN, routine blood sampling was
usually done for all infants at six months of age to
determine their hemoglobin levels. For these infants,
sampling for this study was done at the same time to
avoid multiple pricks. EMLA® (lidocaine) cream, a
topical anesthetic agent was applied at the sampling site
to minimize pain. Tests were carried out at no cost to
the patients. Confidentiality was maintained by using
codes instead of personal identifying information.

Study design
This was a cross-sectional study to determine the
prevalence of vitamin D deficiency in exclusively
breastfed infants at the Well-Baby Clinic of the
Aga Khan University Hospital, Nairobi (AKUHN)
between October 2014 and April 2015. Infants who
fit the following characteristics were included in the
study: a) term (>37 weeks gestational age at birth)
singleton infants aged three to six months old, b)
exclusively breastfed infants, and c) informed consent
was obtained from the parent to participate in the
study. Preterm infants, those receiving Vitamin D
supplements, those with kidney/liver, parathyroid or
bone diseases or malabsorption syndromes and infants
on medication known to alter vitamin D metabolism
(anticonvulsants, anti-tubercular drugs, antifungals,
and antiretrovirals) were excluded from the study. A
flow chart showing the criteria of recruiting infants at
the Aga Khan University Hospital Nairobi, Kenya is
summarized in Figure 1.
Arch Endocrinol Metab.
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Eligible and consented
(n = 108)
Refusals and difficult
blood draws (n = 5)

Ineligible participants
(n = 72):
Not exclusively
breastfed (n = 40)
Not within the age
limit (n = 28)
2 sets of twins (n = 4)

ELECSYS 25OHD total assay

Data collected and
blood samples drawn
(n = 103)

Incomplete data
(n = 2)

Final number of
participants (n = 98)

Reagents – Working solutions

Insufficient volume of
the samples (n = 3)

Figure 1. Flow chart showing the criteria of recruiting infants at the Aga
Khan University Hospital Nairobi, Kenya.

Sample size estimation
Fischer’s formula was used to calculate the sample
size (20).
i.e. N=Z2 P (1-P)
		D2
Where;
N = minimum sample size
Z = standard normal deviation corresponding to 95% confidence interval
(= 1.96) in a 2-tailed test.
P = the expected proportion (50%)
D = degree of precision (10%)
N = 96

The expected proportion was estimated at 50%
to give the largest sample size with a 10% degree of
precision. The choice of the degree of precision value
of 10% was due to financial and time limitations.

Sampling technique
All three to six-month-old infants visiting the well-baby
clinic from October 2014 were evaluated for eligibility.
Recruitment continued until the desired sample
size was achieved; April 2015. A focused physical
examination was done on each of the recruited infants
to assess for skeletal signs of rickets. The outcome of
the examination was recorded in a pre-designed form
(Supplementary data; Appendix III) that was coded
for each participant. This remained in the custody of
the principal investigator. The phlebotomy site was
identified, swabbed with alcohol, and a sample of
Arch Endocrinol Metab.

2 mL of blood was drawn from a vein and collected in
standard sampling tubes (clear red-topped vacutainers).
The specimen bottle for each participant bore the same
unique code as the recruitment form with the patient’s
details. Blood samples were sent to the laboratory and
analyzed daily.

The reagent rack pack (M, R1, and R2) and the
pretreatment reagents (PT1, and PT2) were labeled
as VITD‑T. PT1 Pretreatment reagent 1 (white cap),
1 bottle, 4 mL: Dithiothreitol 1 g/L, pH 5.5. PT2
Pretreatment reagent 2 (gray cap), 1 bottle, 4 mL:
Sodium hydroxide 55 g/L. M Streptavidin-coated
microparticles (transparent cap), 1 bottle, 6.5 mL:
Streptavidin-coated microparticles 0.72 mg/mL;
preservative. R1 Vitamin D binding protein‑BPRu
(gray cap), 1 bottle, 9 mL: Ruthenium labeled
vitamin D binding protein 150 μg/L; bis‑tris propane
buffer 200 mmol/L; albumin (human) 25 g/L; pH 7.5;
preservative. R2 25‑hydroxyvitamin D~biotin (black
cap), 1 bottle, 8.5 mL: Biotinylated vitamin D (25‑OH)
14 μg/L; bis‑tris propane buffer 200 mmol/L; pH
8.6; preservative (21).

Assay
A Cobas analyzer (Roche, Mannheim, Germany)
was used for these measurements according to
manufacturers’ protocols (21). The assay involved a
3-step incubation process, over a 27-minute duration
(21). In the first step, the sample was incubated with
pretreatment reagent, which released bound 25-OH
vitamin D from the vitamin D binding protein (VDBP)
(21). In step 2, the pretreated sample was incubated
with ruthenium labeled VDBP creating a complex
between the 25-OH vitamin D and the ruthenylated
VDBP (21). The third incubation step involved the
addition of streptavidin-coated microparticles and
25-OH vitamin D labeled with biotin (21). The free
sites of the ruthenium labeled VDBP become occupied,
forming a complex consisting of the ruthenium labeled
vitamin D binding protein and the biotinylated
25-OH vitamin D (21). The entire complex then
becomes bound to the solid phase via interaction of
biotin and streptavidin (21). The reaction mixture
was then aspirated into the measuring cell where the
microparticles were magnetically captured onto the
3
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Participants assessed
for eligibility (n = 180)
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surface of the electrode (21). Unbound substances were
then removed with ProCell/ProCell M. Application of
a voltage to the electrode induced a chemiluminescent
emission which was measured by a photomultiplier
(21). Results were determined via a calibration curve
which was instrument specifically generated by 2‑point
calibration and a master curve provided via the reagent
barcode (21). 25OHD was reported in nanograms per
milliliter (ng/mL) (21).

ELECSYS PTH assay

Reagents – Working solutions
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The reagent rack pack was labeled as PTH (22).
Streptavidin-coated microparticles (transparent cap),
1 bottle, 6.5 mL: Streptavidin-coated microparticles
0.72 mg/mL; preservative. R1 Anti-PTH Ab~biotin
(gray cap), 1 bottle, 7 mL: Biotinylated monoclonal
anti‑PTH antibody (mouse) 2.3 mg/L; phosphate
buffer 100 mmol/L, pH 7.0; preservative. R2 AntiPTH-Ab~Ru(bpy) (black cap), 1 bottle, 7 mL:
Monoclonal anti‑PTH antibody (mouse) labeled with
ruthenium complex 2.0 mg/L; phosphate buffer 100
mmol/L, pH 7.0; preservative (22).

Calcium and phosphate assay
A Cobas analyzer (Roche, Mannheim, Germany) which
uses the electrochemiluminescence (ECLIA) assay
principle was used for these measurements (23,24). The
precision of this analyzer is summarized in (Appendix
VI and VII).

Data handling and analysis
The collected data were entered into Microsoft Excel®.
25OHD, calcium, phosphate, and PTH were analyzed
by descriptive statistics. Proportions were used in the
analysis of vitamin D prevalence and the mean levels
PTH, calcium, and phosphate in the VDD, VDI, and
VDS groups were compared by One Way Analysis of
Variance (ANOVA) and Bonferroni test as post hoc
test. The relationship between PTH and 25OHD was
determined by scatter plot analysis and odds ratio was
used to determine the relationship between infant serum
25OHD and maternal vitamin D supplementation and
sunlight exposure. p<0.05 was considered significant in
all cases. GenStat 15th edition and SPSS version 20.0
were used.

Assay

RESULTS

A Cobas analyzer (Roche, Mannheim, Germany)
was used for these measurements according to
manufacturers’ instructions (22). The assay involved a
2-step incubation process, over an 18-minute duration
of time (22). Step 1 involved incubating 50 μL of
the sample, a biotinylated monoclonal PTH‑specific
antibody, and a monoclonal PTH‑specific antibody
labeled with a ruthenium complex to form a sandwich
complex (22). Step 2 involved the addition of
streptavidin-coated microparticles, and the complex
became bound to the solid phase via the interaction
of biotin and streptavidin (22). The reaction mixture
was then aspirated into the measuring cell where the
microparticles were magnetically captured onto the
surface of the electrode (22). Unbound substances were
then removed with ProCell/ProCell M. Application of
a voltage to the electrode induced chemiluminescent
emission which was measured by a photomultiplier
(22). Results were determined via a calibration curve
which was instrument generated by 2‑point calibration
and a master curve provided via the reagent barcode
(22). PTH levels were reported as picograms/milliliter
(pg/mL) (22).

Socio-demographics of the study participants
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The mean age of the recruited infants was 4.6 months.
54.1% (53/98) were male and 45.9% (45/98) were
female.

Prevalence of vitamin D deficiency
The prevalence of vitamin D deficiency (25OHD
<12 ng/mL) among exclusively breastfed infants at
AKUHN was 11.2% (95% CI: 8.0%-14.4%), and 12.2%
(95% CI: 8.9%-15.5%) were found to have insufficient
levels (12 ng/mL to 20 ng/mL) while 76.5% (95% CI:
72.3%-80.8%) had a sufficient level

Relationship between 25OHD, phosphate, calcium,
and parathyroid hormone (PTH)
Table 1 is a summary of the mean values of
sociodemographic and clinical variables of infants at
the Aga Khan University Hospital, Nairobi. There
was no significant difference in the mean age, head
circumference, length, or weight of infants in the
VDD, VDI, and VDS groups (Table 1). The mean
phosphate level in the VDD group was significantly
Arch Endocrinol Metab.
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(p<0.05) lower than the mean levels in the VDI and
VDS groups (Table 1). The mean parathyroid level
in the VDD group was significantly (p<0.05) higher
than the mean levels in the VDI and VDS groups
(Table 1). There was no significant difference in the
mean calcium levels of VDD, VDI, and, VDS groups
(Table 1). There was a positive and direct relationship
between 25OHD and calcium and phosphate
(Figure 2). This relationship was more discernible at
25OHD < 30 ng/mL (Figure 2). PTH was mostly
elevated when 25OHD was < 12 ng/mL (Figure 3).
PTH was normal when 25OHD was between 12 ng/mL
to 20 ng/mL (Figure 3). However 6 infants had
elevated PTH despite having 25OHD between 20
and 30 ng/mL (Figure 3).

25OHD (ng/ml)

60

40

20

0

0

50

100

150

200

250

300

PTH (pg/mL)

Figure 3. Relationship between 25OHD and PTH in infants at the Aga
Khan University Hospital Nairobi, Kenya.

Table 1. Summary of the mean values of sociodemographic and clinical variables of infants at the Aga Khan University Hospital
Variable
Socio demographic variables
Age (months)
Head circumference (cm)
Length (cm)
Weight (cm)
Clinical variables
Calcium (mmol/L)
Phosphate (mmol/L)
25OHD (ng/mL)
PTH (pg/mL)

VDD
(n:11)

VDI
(n:12)

VDS
(n:75)

4.3 (1.2)a
43.7 (1.4)a
63.0 (2.2)a
7.6 (1.2)a

4.2 (0.8)a
42.5 (0.7)a
62.5 (2.0)a
6.8 (0.7)a

4.8 (1.0)a
43.0 (1.8)a
63.4 (3.5)a
7.4 (1.2)a

2.5 (0.2)a
1.6 (0.2)a
7.9 (3.1)a
145.3 (74.6)b

2.6 (0.2)a
2.0 (0.5)b
16.8 (2.3)a
35.5 (13.9)a

2.7 (0.2)a
2.0 (0.2)b
35.8 (11.3)b
37.4 (22.8)a

Values expressed as means and standard deviation. One-Way ANOVA and Bonferroni post hoc test was used. Means with different superscripts across the rows are significantly different at p<0.05.
VDD: vitamin D deficiency; VDI: vitamin D insufficiency; VDS: vitamin D sufficiency.
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Figure 2. Relationship between 25OHD and serum calcium and phosphate in infants at the Aga Khan University Hospital Nairobi, Kenya.
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Maternal vitamin D supplementation and rachitic
manifestations in infants
There were four infants whose mothers were on vitamin D
supplementation (Figure 4). All of these infants had
50

sufficient 25OHD and none had elevated PTH. About
4/98 (4.1%) of the infants manifested skeletal signs of
rickets. Figure 5 is a summary of the metabolic features
of infants with skeletal manifestations of rickets.
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Infants whose mothers had vitamin D supplementation
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Ca (mmol/L)

Phosp (mmol/l)

Figure 4. 25OHD, PTH, calcium, and phosphate in infants at the Aga Khan University Hospital, Nairobi, Kenya whose mothers had vitamin D supplementation.
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25OHD (ng/mL)

PTH (pg/mL)
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Figure 5. Metabolic features of infants with skeletal manifestations of rickets at the Aga Khan University Hospital Nairobi, Kenya
6

Arch Endocrinol Metab.

VDD in exclusively breastfed infants

Relationship between 25OHD and sunlight exposure
in infants and mothers

including the American Institute of Medicine (IOM),
the UK Scientific Advisory Committee on Nutrition,
the Nordic Nutritional Recommendations, and the
European Food Safety Authority (8-11).
We observed that infants whose mothers had
received vitamin D supplementation had normal levels
of calcium, phosphate, and 25OHD ≥30 ng/mL. This
suggests that maternal vitamin D supplementation
during pregnancy and breastfeeding may be beneficial
in staving off vitamin D deficiency in exclusively
breastfed infants.
The finding that even the severely vitamin D-deficient
infants had serum calcium and phosphate levels that were
within normal reference limits supports the specification
of vitamin D deficiency being at 25OHD <12 ng/mL.
The reference values for parathyroid hormone (PTH)
in infants is between 9.4 and 66 ng/mL (28). On visual
inspection parathyroid hormone (PTH) was elevated
when 25OHD was below 12 ng/mL, and PTH were
all normal when 25OHD was between 12 ng/mL to
20 ng/mL. Active vitamin D (calcitriol) facilitates the
absorption of calcium and phosphorous from the gut
and its deficiency reduces calcium absorption and serum
calcium levels, which triggers greater PTH synthesis
(28). PTH elevation was observed in 6 infants who
had 25OHD between 20 and 30 ng/mL and normal
calcium and phosphate. Possible explanations may be
that there may have been low maternal calcium intake or
that the infants may have had some renal impairment/
malabsorption syndromes. However, we believe that
the reduced maternal calcium may be a more likely
explanation for the PTH elevation. This is because not
only was there no stunted development of observed
in infants during physical examination but also part
of our infant recruitment strategy involved excluding
infants with kidney/renal impairment, malabsorption
syndromes, and those on medication known to alter

Infants with <30 minutes of exposure to sunlight were
5 times more likely to have vitamin D insufficiency
than infants who received ≥30 minutes of exposure to
sunlight (p=0.042) – Table 2.

DISCUSSION
To the best of our knowledge, this is the first study
to determine the prevalence of VDD in exclusively
breastfed infants in the study area. Considering that
the region receives adequate UV radiation throughout
the year (25) this prevalence is somewhat unexpected.
It is plausible that this finding may have something
to do with the fact that some of the participating
infants had been born during or before the 3 coldest
months of the year i.e. July, August, and September
when temperatures were as low as 9 °C (26). There
is a tendency for mothers to wrap their babies in
multiple layers of clothing during harsh (cold) weather
conditions to keep them warm. This is particularly true
when the infants are outdoors. Therefore, not only is
infant sun exposure occluded but also the cutaneous
synthesis of vitamin D is impaired.
The prevalence rate we have reported was lower
than what was reported in a similar study at the Rubaga
hospital in Kampala, Uganda (27). This observation
may be the result of differences in policy between the
two hospitals. Sun exposure is impressed upon mothers
at discharge from the postnatal unit of AKUHN and
every well-baby clinic visit thereafter. This is in light of
findings by Dodia and cols. who observed that there
was a high prevalence of VDD in newly delivered
mothers at AKUHN (16). Through this study, the
cut-off value for VDD in the study area has been
determined for the first time. The value is within the
clinical threshold set by various global health authorities

Table 2. Relationship between exposure to sunlight in infants and mothers and 25OHD in infants at the Aga Khan University Hospital Nairobi, Kenya
Optimal exposure to sunlight

Status

Odds ratio

Confidence
intervals

Mothers
p value

Odds ratio

Confidence
intervals

p value

VDS

1.0

-

-

1.0

-

-

VDI

4.98

1.06-23.36

0.04*

0.63

0.15-2.61

0.53

VDD

1.35

0.31-5.73

0.53

0.66

0.15-2.82

0.58

Copyright© AE&M all rights reserved.

Infants

VDS: vitamin D sufficient; VDI: vitamin D insufficient; VDD: vitamin D deficient. * Significant at p<0.05.
Arch Endocrinol Metab.
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vitamin D metabolism i.e. anticonvulsants, antitubercular drugs, antifungals, and antiretrovirals).
Less than 5% of study participants had signs of rickets
(wrist prominence, Harrison’s sulcus, and a rachitic
rosary). This observation, when taken in the context
of the 11.2% of infants who had VDD and the 12.2%
of infants who had VDI suggests that skeletal features
may be late manifestations of vitamin D deficiency and
therefore there may be a need to review the use of
these features in informing clinical decisions relevant to
vitamin D deficiency.
In conclusions, our findings suggest that the
prevalence of VDD among exclusively breastfed
infants in the study area is low. The current policy that
recommends the exclusive breastfeeding of infants in
Kenya until they are six months of age appears to be
effective in staving of vitamin D deficiency and should
be promoted in hospitals with similar infrastructure as
Aga Khan University Hospital, Nairobi. Because of the
higher risk of vitamin insufficiency in infants with <30
minutes of sunlight exposure, low dose supplemental
vitamin D during times of low sunlight exposure may
be recommended.
Limitations: sun exposure data collected for this study was self-reported and therefore subject to some degree of bias. The
amount of skin surface area exposed, the use of sunscreens, and
the amount of cloud cover in the study participants was also not
determined. All these factors affect the cutaneous synthesis of vitamin D. The PTH cut-offs used were extrapolated from studies
of the general population, which also includes vitamin D deficient
individuals, and may therefore not reflect the true cut-off for normal infants.
Funding: this work was undertaken with the financial support
from the Aga Khan University Research Council. REF: 2014/
REC-23(v2).
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